v3.25.4
Condensed Consolidated Balance Sheets - USD ($)
Oct. 31, 2025
Apr. 30, 2025
Current assets:    
Cash $ 63 $ 1,493
Inventory 7,599 7,599
Total current assets 7,662 9,092
Total assets 7,662 9,092
Current liabilities:    
Accounts payable and accrued expense 197,596 172,082
Accrued licenses agreement payable 50,000 25,000
Accrued interest and fees payable 233,491 220,521
Convertible notes payable, net of discount 215,392 185,762
Derivative liabilities 53,333 31,866
Payables - related parties 937,877 747,208
Customer deposits 40,375 40,375
Stock payable 24,000 24,000
Notes payable 541,288 476,312
Note payable- related party 183,662 161,092
Total current liabilities 2,477,014 2,084,218
Total liabilities 2,477,014 2,084,218
Commitments and Contingencies 0 0
Stockholders' deficit:    
Common stock, $0.0001 par value; 600,000,000 shares authorized, 35,776,558 and 34,147,891 shares issued and outstanding, respectively 3,754 3,416
Additional paid-in capital 16,352,533 16,324,169
Accumulated deficit (18,439,015) (18,042,197)
Total (2,082,355) (1,714,249)
Non-controlling interest (386,997) (360,877)
Total stockholders' deficit (2,469,352) (2,075,126)
Total liabilities and stockholders' deficit 7,662 9,092
Series A Preferred Stock    
Stockholders' deficit:    
Preferred stock value 253 253
Series B Preferred Stock [Member]    
Stockholders' deficit:    
Preferred stock value 120 110
Series D Preferred Stock    
Stockholders' deficit:    
Preferred stock value $ 0 $ 0